L. Larivière

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

R. Fedorak, R. Bailey, M. Poleski, 1997, Gastroenterology.

Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID

M. Baird, M. Juneau, L. Annable, 1995, Cardiovascular Drugs and Therapy.

Three-month efficacy and safety of once-daily diltiazem in chronic stable angina pectoris.

M. Alexander, M. Baird, C. Nadeau, 1995, The American journal of cardiology.

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

D. Bichet, J. Marc‐aurèle, G. Caillé, 1991, Biopharmaceutics & drug disposition.

Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers

D. Bichet, J. Marc‐aurèle, G. Caillé, 1991, Biopharmaceutics & drug disposition.

Placebo‐controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety

C. Montigny, J. Ouellette, G. Caillé, 1988, Biopharmaceutics & drug disposition.